(Press-News.org) Cervical cancer is a serious global health threat which kills more than 300,000 women every year. It's a disease that disproportionately affects women in low- and middle-income countries in equatorial Africa, Latin America and Southeast Asia, yet it is a preventable disease and decades of research have produced the tools needed to eliminate it.
Recognizing this urgent public health issue, the editorial team of Preventive Medicine, led by Editor-in-Chief Dr. Eduardo Franco, Director, Division of Cancer Epidemiology and Chair, Gerald Bronfman Department of Oncology at McGill University, is publishing a special issue titled "From Science to Action to Impact: Eliminating Cervical Cancer," which outlines the required courses of action to eliminate cervical cancer.
The journal's publication coincides with International HPV Awareness Day on March 4 and is dedicated to the more than half a million women who are struck by cervical cancer every year. Its publication follows the official launch last November of the World Health Organization (WHO) strategy to accelerate the elimination of cervical cancer. The strategy outlines targets for all countries to achieve by the year 2030: 90 percent human papillomavirus (HPV) vaccination coverage to prevent the infections that cause cervical cancer, 70 percent screening coverage, and 90 percent access to treatment for women identified with cervical disease.
Dr. Anna Giuliano and Dr. Linda Niccolai, two giants in the field of cervical cancer prevention research, served as guest editors for the issue. Dr. Giuliano, Director of the Center for Immunization and Infection Research in Cancer and Professor in the Department of Cancer Epidemiology at the Moffitt Cancer Center, and Dr. Niccolai, Professor of Epidemiology, Yale School of Public Health, Director of the Connecticut Emerging Infections Program, and member of Yale Cancer Center, assembled an outstanding group of international scientists and practitioners who contributed papers on basic science, clinical medicine, public health practice and mathematical modeling, all focused on the targeted action needed in each of these realms to achieve cervical cancer elimination.
"In the history of medicine, we never dared to conjugate the verb 'eliminate' with respect to cancer," says Dr. Franco. "The toll in human suffering for a disease that is preventable makes the elimination of cervical cancer a moral goal that we have an ethical obligation to achieve. HPV vaccination can prevent the vast majority of cervical cancers and molecular HPV testing is a great technology to detect the remaining precancerous lesions that are not prevented. These two preventive strategies must be deployed on a global scale."
In their editorial, Drs. Giuliano and Niccolai emphasize that in addition to public health and clinical resources for research and health care, there is a critical need for government officials to take a strong stand. "We have all the tools we need for cervical cancer elimination: vaccination, screening and treatment, for both primary and secondary prevention," says Dr. Niccolai. "What we need now is the commitment of political, medical and public health officials to make this happen." Dr. Giuliano further explains, "The articles in this issue were selected to encapsulate the knowledge we have and effort needed to reach global cervical cancer elimination. Our intent was to inspire action globally among scientists, health care providers, policy leaders and communities to accelerate progress toward this attainable goal."
The COVID-19 pandemic has created both challenges and opportunities regarding global efforts to conduct HPV screening and vaccination. "The pandemic has taught us how to be agile and creative, and how to work toward health promotion under the most difficult of circumstances. It has forced us to reimagine how we deliver health care including preventive services," says Dr. Niccolai. "It has also highlighted for the public the powerful potential of vaccines to protect our health."
"We are delighted to place Preventive Medicine, a respected journal that has an international readership in public health, to the service of this great cause," says Dr. Franco, who has served as Editor-in Chief since 2013. "Drs. Giuliano and Niccolai have done an outstanding job. This special issue of the journal presents a technically feasible and realistic roadmap for facing the great challenge of eliminating cervical cancer."
INFORMATION:
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt's expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.
About Preventive Medicine
Founded in 1972 by Ernst Wynder, Preventive Medicine is an international scholarly journal that publishes original articles on the science and practice of disease prevention, health promotion, and public health policymaking. Preventive Medicine aims to reward innovation. It favors insightful observational studies, thoughtful explorations of health data, unsuspected new angles for existing hypotheses, robust randomized controlled trials, and impartial systematic reviews. Preventive Medicine's ultimate goal is to publish research that will have an impact on the work of practitioners of disease prevention and health promotion, as well as of related disciplines.
Researchers in Japan have developed the first wearable devices to precisely monitor jaundice, a yellowing of the skin caused by elevated bilirubin levels in the blood that can cause severe medical conditions in newborns. Jaundice can be treated easily by irradiating the infant with blue light that breaks bilirubin down to be excreted through urine. The treatment itself, however, can disrupt bonding time, cause dehydration and increase the risks of allergic diseases. Neonatal jaundice is one of the leading causes of death and brain damage in infants in low- and middle-income countries.
To address the tricky balance ...
On Earth, plate tectonics is not only responsible for the rise of mountains and earthquakes. It is also an essential part of the cycle that brings material from the planet's interior to the surface and the atmosphere, and then transports it back beneath the Earth's crust. Tectonics thus has a vital influence on the conditions that ultimately make Earth habitable.
Until now, researchers have found no evidence of global tectonic activity on planets outside our solar system. A team of researchers led by Tobias Meier from the Center for Space and Habitability (CSH) at the University of Bern and with the participation of ETH Zurich, the University of Oxford and the National Center of Competence in Research NCCR PlanetS has now found evidence of the flow patterns inside ...
Female gannets travel further than male gannets to find fish for their chicks in some years but not others, new research shows.
Scientists tracked breeding gannets from Grassholm Island in Wales over 11 years with tiny GPS devices and by measuring isotopic signatures in their blood.
Male gannets flew an average of 220km to forage for their chicks, while females averaged 260km. Some birds travelled 1,000km on a single trip.
The scientists also found that the two sexes selected different habitats and foraged at different times of day, but some years ...
COLUMBUS, Ohio - Putting a price on producing carbon is the cheapest, most efficient policy change legislators can make to reduce emissions that cause climate change, new research suggests.
The case study, published recently in the journal Current Sustainable/Renewable Energy Reports, analyzed the costs and effects that a variety of policy changes would have on reducing carbon dioxide emissions from electricity generation in Texas and found that adding a price, based on the cost of climate change, to carbon was the most effective.
"If the goal is reducing carbon dioxide in the atmosphere, what we found is that putting a price on carbon and then letting suppliers and consumers make their ...
In order to show the clinical relevance of a difference between two treatment alternatives, in recent years, the manufacturer dossiers submitted in early benefit assessments of new drugs have increasingly contained responder analyses for patient-relevant outcomes. In such analyses, it is investigated whether the proportion of patients experiencing a noticeable change in the respective outcome differs between the two treatment groups in a study. This involves information on health-related quality of life or on individual symptoms such as pain or itching, which patients recorded with the help of scales in questionnaires.
But what difference makes a change relevant for the individual? That is, at what threshold can a response to an intervention be derived for ...
A deep sequencing study of 747 SARS-CoV-2 virus isolates has revealed mutant peptides derived from the virus that cannot effectively bind to critical proteins on the surface of infected cells and, in turn, hamper activation of CD8+ killer T cells that recognize and destroy these infected cells. These peptides, the authors say, represent one way the coronavirus subverts killer T cell responses and stymies immunity in the host. Their results may be of particular importance for SARS-CoV-2 subunit vaccines, such as the RNA vaccines currently in use, which induce responses against a limited number of viral ...
There are no therapeutics available that have been developed for COVID-19 treatment. Repurposing of already available medication for COVID-19 therapy is an attractive option to shorten the road to treatment development. The drug Camostat could be suitable. Camostat exerts antiviral activity by blocking the protease TMPRSS2, which is used by SARS-CoV-2 for entry into cells. However, it was previously unknown whether SARS-CoV-2 can use TMPRSS2-related proteases for cell entry and whether these proteases can be blocked by Camostat. Moreover, it was unclear whether metabolization of Camostat interferes with antiviral activity. An international team of researchers around Markus Hoffmann and Stefan Pöhlmann ...
Solving a Genetic Mystery at the Heart of the COVID-19 Pandemic
As the COVID-19 pandemic enters its second year, scientists are still working to understand how the new strain of coronavirus evolved, and how it became so much more dangerous than other coronaviruses, which humans have been living alongside for millennia.
Virologists and epidemiologists worldwide have speculated for months that a protein called ORF8 likely holds the answer, and a recent study by Berkeley Lab scientists has helped confirm this hypothesis.
In a paper published in mBio, lead author Russell Neches and his colleagues ...
By embedding a silver catalyst inside a porous crystal, KAUST researchers have improved a chemical reaction that converts carbon dioxide (CO2) into carbon monoxide (CO), which is a useful feedstock for the chemical industry.
Carbon monoxide is a building block for producing hydrocarbon fuels, and many researchers are searching for ways to produce it from CO2, a greenhouse gas emitted by burning fossil fuels. One strategy involves using electricity and a catalyst to drive a so-called CO2 reduction reaction. But this reaction typically produces a variety of other products, including methane, methanol and ethylene. Separating these products significantly raises the cost of the process, ...
A study on big droughts in the Greater Mekong region revealed findings that can help reduce the carbon footprint of power systems while providing insights into better designed and more sustainable power plants.
The study, titled 'The Greater Mekong's climate-water-energy nexus: how ENSO-triggered regional droughts affect power supply and CO2 emissions', was published by researchers from the Singapore University of Technology and Design (SUTD) and the University of California, Santa Barbara, in the journal Earth's Future.
Known as an important means to support economic growth in Southeast Asia, the hydropower resources of the Mekong River Basin have been largely exploited by the riparian countries. The researchers ...
